Eric Harl, PA
Medical · Minneapolis, MNNPI 1336297043
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 8 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Novartis at 22.2% of the total. That places this record below the midpoint for medical clinicians in MN, where the typical reported total is $112.
Across 8 payments — averaging $16.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$29
- Incyte Corporation$25
- Sanofi$17
- Sun Pharmaceutical Industries Inc.$16
- Verrica Pharmaceuticals Inc.$16
- E.r. Squibb & Sons, L.L.C.$14
- plus $14 from 1 others
What the payments were for
- Food & beverage$131100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 2 | $29 |
| Incyte Corporation | 1 | $25 |
| Sanofi | 1 | $17 |
| Sun Pharmaceutical Industries Inc. | 1 | $16 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
How this compares
$131 in reported general payments places this provider in the 50th percentile of 202 medical providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 37 | $40,611 |
| EliquisApixaban | 30 | $33,248 |
| JanumetSitagliptin Phos/Metformin Hcl | 12 | $11,571 |
| JanuviaSitagliptin Phosphate | 15 | $11,516 |
| Repatha PushtronexEvolocumab | 12 | $8,409 |
| XareltoRivaroxaban | 11 | $7,822 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 20 | $2,624 |
| Atorvastatin Calcium | 151 | $2,477 |
| Rosuvastatin Calcium | 90 | $2,465 |
| Nifedipine ErNifedipine | 76 | $2,189 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 65 | $1,867 |
| Amlodipine Besylate | 133 | $1,808 |
| Losartan Potassium | 98 | $1,660 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,495 |
| Levemir FlexpenInsulin Detemir | 13 | $1,444 |
Paid to pharmacies, not to this prescriber.
Other medical in Minneapolis
- Steven AtkinsonMinneapolis$2K
- Kimberly McCaughanMinneapolis$2K
- Ashley KonstantinidesMinneapolis$929
- Nadine MillerMinneapolis$904
- Anne HendricksonMinneapolis$767
- Kristina ThissenRogers$178K
- Cynthia KonrathMinnetonka$95K
- Tyler JohnsonWaconia$28K
- Eliza AbrahamWhite Bear Lake$19K
- Tobie MeyerMaple Grove$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.